Amgen (AMGN) Latest Can Amgen Turn Around? Markets Newsletter editor George Putnam thinks the struggling biotech giant will rebound. He's worth a listen. Markets Amgen: Biotech Value Markets Shares of this biotechnology giant have suffered -- yet the company's pipeline and growth strategy look as healthy as ever. By Staff Published 22 May 06 Markets Amgen: Biotech Promise Markets Shares of the world's largest biotech company should perform well in 2006, says one analyst. By Staff Published 9 January 06 Markets 1 2 3 4
